John V Heymach Selected Research

John V Heymach Research Topics

Disease

208	Neoplasms (Cancer) 04/2024 - 09/2004
148	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2006
75	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2004
26	Neoplasm Metastasis (Metastasis) 10/2023 - 09/2012
24	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 06/2004
23	Adenocarcinoma of Lung 10/2023 - 10/2006
14	Disease Progression 01/2024 - 05/2009
12	Squamous Cell Carcinoma of Head and Neck 01/2023 - 06/2010
11	Hypoxia (Hypoxemia) 01/2021 - 02/2007
10	Carcinogenesis 09/2023 - 01/2012
7	Melanoma (Melanoma, Malignant) 01/2022 - 04/2010
7	Adenocarcinoma 03/2021 - 07/2015
6	Pneumonia (Pneumonitis) 11/2023 - 01/2019
6	Breast Neoplasms (Breast Cancer) 12/2018 - 12/2008
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2021 - 10/2017
5	Brain Neoplasms (Brain Tumor) 01/2021 - 06/2008
5	Exanthema (Rash) 01/2020 - 07/2010
4	Bites and Stings (Sting) 12/2023 - 01/2019
4	Malignant Mesothelioma 10/2020 - 06/2008
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 04/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2015 - 05/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 05/2014
3	COVID-19 11/2021 - 01/2021
3	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 07/2011
3	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 09/2004
3	Carcinoma (Carcinomatosis) 01/2020 - 10/2006
3	Ovarian Neoplasms (Ovarian Cancer) 04/2017 - 01/2007
3	Leukemia 01/2017 - 05/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 01/2010

Drug/Important Bio-Agent (IBA)

36	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2007
31	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2008
30	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2016
24	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 05/2005
22	ErbB Receptors (EGF Receptor)IBA 01/2023 - 07/2006
18	Tyrosine Kinase InhibitorsIBA 09/2023 - 05/2007
15	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 07/2006
15	vandetanib (ZD6474)IBA 04/2016 - 07/2006
13	CytokinesIBA 01/2023 - 01/2010
13	Phosphotransferases (Kinase)IBA 10/2022 - 12/2007
12	LigandsIBA 03/2023 - 09/2012
11	PlatinumIBA 02/2024 - 08/2011
11	RNA (Ribonucleic Acid)IBA 02/2024 - 02/2016
11	Bevacizumab (Avastin)FDA Link 07/2022 - 03/2006
11	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2016
11	Angiogenesis InhibitorsIBA 10/2019 - 09/2004
10	Docetaxel (Taxotere)FDA Link 02/2024 - 01/2007
9	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 11/2008
9	Circulating Tumor DNAIBA 01/2022 - 03/2016
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2012
8	NivolumabIBA 10/2023 - 01/2018
8	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 10/2017
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 02/2007
8	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2012 - 09/2004
7	IpilimumabIBA 10/2023 - 12/2019
7	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 11/2008
7	AntigensIBA 01/2023 - 05/2014
7	Gefitinib (Iressa)FDA Link 05/2009 - 07/2006
6	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2007
6	osimertinibIBA 11/2023 - 12/2018
6	B7-H1 AntigenIBA 11/2023 - 02/2016
6	HM781-36BIBA 01/2023 - 10/2019
6	Messenger RNA (mRNA)IBA 01/2020 - 05/2008
5	durvalumabIBA 02/2024 - 01/2022
5	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 06/2011
5	pembrolizumabIBA 01/2023 - 01/2020
5	AntibodiesIBA 01/2023 - 04/2011
5	Peptides (Polypeptides)IBA 01/2022 - 03/2014
4	Transcription Factors (Transcription Factor)IBA 03/2024 - 08/2009
4	ChemokinesIBA 03/2023 - 07/2011
4	NucleotidesIBA 01/2022 - 08/2013
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2018 - 11/2013
4	Cetuximab (Erbitux)FDA Link 12/2013 - 07/2006
3	Etoposide (VP 16)FDA LinkGeneric 02/2024 - 12/2023
3	atezolizumabIBA 02/2024 - 01/2021
3	InterleukinsIBA 01/2022 - 03/2010
3	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 09/2012
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021 - 03/2010
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 05/2012
3	Protons (Proton)IBA 01/2020 - 01/2017
3	Small Interfering RNA (siRNA)IBA 01/2020 - 04/2017
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 08/2013
3	cediranib (AZD2171)IBA 10/2019 - 08/2007
3	MicroRNAs (MicroRNA)IBA 01/2019 - 08/2014
3	EnzymesIBA 01/2019 - 01/2010
3	pazopanib FDA Link 01/2018 - 03/2010
3	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2017 - 09/2008
3	Sunitinib (Sutent)FDA Link 11/2012 - 05/2007
3	afliberceptIBA 11/2011 - 12/2008
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2011 - 01/2005
2	tepotinibIBA 08/2023 - 01/2020
2	CrizotinibIBA 08/2023 - 02/2023
2	Everolimus FDA Link 02/2023 - 07/2015

Therapy/Procedure

100	Therapeutics 02/2024 - 01/2005
45	Drug Therapy (Chemotherapy) 02/2024 - 06/2004
42	Radiotherapy 02/2024 - 04/2011
39	Immunotherapy 02/2024 - 01/2016
9	Neoadjuvant Therapy 10/2023 - 01/2018
5	Aftercare (After-Treatment) 11/2022 - 09/2016
4	Chemoradiotherapy 01/2023 - 01/2013
3	Proton Therapy 02/2024 - 01/2018